According to Pro Football Focus, it is Duke wide receiver Eli Pancol -- an unsurprising pick due to his rare physical traits and clear upside. "Travis Hunter’s arrival completely changes the ...

The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle with giants Eli Lilly and Novo Nordisk for a share of the multibillion-dollar ...

Jared Kushner and Ivanka Trump attend the Manus x Machina Fashion in an Age of Technology Costume Institute Gala at the Metropolitan Museum of Art — Photo by ...

Eli Roth‘s recently-launched company The Horror Section has signed a deal with Construction Film, the German-based production banner founded by producer and actress Veronica Ferres (“The ...

HOUSTON — Eli Lilly & Co. (NYSE: LLY), one of the largest pharmaceutical manufacturers in the world, could be the latest major manufacturer moving into Houston. The Indianapolis-based drugmaker ...

Philadelphia Eagles cornerback Eli Ricks fired off another flirty message to Ivanka Trump, the daughter of President Donald Trump, on Friday following her visit to the Eagles’ facility.

Philadelphia Eagles cornerback Eli Ricks publicly expressed his admiration for Ivanka Trump on X after seeing her in person. Ivanka responded by leaving a note for Ricks at the Eagles' facility ...

Eli Lilly (NYSE: LLY) has a strong pipeline of new medicines that could increase the stock price. *Stock prices used were the afternoon prices of May 15, 2025. The video was published on May 17 ...

Eli Lilly’s total deal value with Rznomics could exceed $1.3 billion, plus royalties. Rznomics will lead early-stage research; Lilly to handle development and sales. Don’t miss this list of 3 ...

Israel has long sought to bring home from Syria the remains of Eli Cohen, whose spying work is credited with helping Israel win the Arab-Israeli War of 1967. By Claire Moses For decades ...

Meanwhile, Eli Lilly's Zepbound injection has gained traction, prompting both firms to race toward more convenient weight?loss pills. Investors will watch upcoming trial readouts and regulatory ...

On May 16, Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural hearing loss, with milestone payments exceeding $1.3 billion.